21,721 Shares in Cibus, Inc. (NASDAQ:CBUS) Acquired by Squarepoint Ops LLC

Squarepoint Ops LLC acquired a new stake in Cibus, Inc. (NASDAQ:CBUSFree Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 21,721 shares of the company’s stock, valued at approximately $214,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. FineMark National Bank & Trust raised its position in shares of Cibus by 24.3% during the 2nd quarter. FineMark National Bank & Trust now owns 20,488 shares of the company’s stock valued at $202,000 after acquiring an additional 4,000 shares during the last quarter. Rhumbline Advisers acquired a new stake in shares of Cibus during the second quarter worth $221,000. Old West Investment Management LLC increased its holdings in Cibus by 3.6% in the second quarter. Old West Investment Management LLC now owns 53,247 shares of the company’s stock valued at $524,000 after purchasing an additional 1,868 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in Cibus in the second quarter valued at about $529,000. Finally, Vanguard Group Inc. boosted its holdings in Cibus by 3.7% during the first quarter. Vanguard Group Inc. now owns 721,945 shares of the company’s stock worth $16,215,000 after buying an additional 26,017 shares during the last quarter. 33.81% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently commented on CBUS. Alliance Global Partners lowered their price target on Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a research note on Tuesday, September 24th. Canaccord Genuity Group raised shares of Cibus to a “strong-buy” rating in a research note on Friday, July 19th. Finally, Canaccord Genuity Group reduced their price target on shares of Cibus from $21.00 to $20.00 and set a “buy” rating on the stock in a research report on Thursday, September 19th.

Check Out Our Latest Stock Report on CBUS

Cibus Price Performance

NASDAQ:CBUS opened at $3.70 on Friday. The business’s 50-day simple moving average is $5.49 and its 200-day simple moving average is $10.93. Cibus, Inc. has a fifty-two week low of $2.86 and a fifty-two week high of $23.18. The stock has a market capitalization of $85.43 million, a PE ratio of -0.23 and a beta of 1.81.

Cibus (NASDAQ:CBUSGet Free Report) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($1.14) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.81) by ($0.33). The company had revenue of $0.84 million during the quarter, compared to the consensus estimate of $0.44 million. Cibus had a negative net margin of 9,856.84% and a negative return on equity of 29.05%. During the same period in the previous year, the firm posted ($3.05) EPS. On average, research analysts expect that Cibus, Inc. will post -3.84 earnings per share for the current year.

About Cibus

(Free Report)

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.

See Also

Want to see what other hedge funds are holding CBUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cibus, Inc. (NASDAQ:CBUSFree Report).

Institutional Ownership by Quarter for Cibus (NASDAQ:CBUS)

Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.